Corona Remedies IPO: Retail investors have taken up 87% of their quota, while non institutional investors have subscribed 79% of their portion. Qualified institutional buyers are yet to make any meaningful bid.
Corona Remedies IPO: Retail investors have taken up 87% of their quota, while non institutional investors have subscribed 79% of their portion. Qualified institutional buyers are yet to make any meaningful bid.